Latest Sales Performance News

Osteopore has inked a three-year distribution agreement with Al-Umnia Medical to bring its 3D-printed orthopaedic implants to five Gulf countries, targeting a rapidly expanding regional market.

ECS Botanics plans to introduce two 2g all-in-one vape products under its OzSun brand in mid-August 2026, expanding its higher-margin B2C portfolio with a capital-efficient supply model.

AdNeo Limited achieved a record positive operating cash flow of $451k in Q4 FY26 and secured significant customer contracts, setting the stage for disciplined growth in FY27.

South32 has outperformed its FY26 production guidance, boosted quarterly sales by 15%, and announced a strategic sale of aluminium assets to Alcoa for up to US$5.6 billion, pivoting towards a base metals-focused portfolio.

Immuron Limited reported a 6% increase in FY26 sales to AUD 7.7 million, driven by strong gains in Canada and the US despite mixed Australian performance. Marketing initiatives and retail expansion underpin growth.

Freehill Mining’s aggregates business posted a record $1.36 million in quarterly sales, up 47% from the prior quarter, driven by plant improvements and a broadening customer base. June alone saw a record $496,000 in sales, underpinning the company’s copper project ambitions.

Prophecy International has launched a sweeping global organisational restructure that will slash its workforce by approximately 48%, aiming to realign operations and reduce costs ahead of its FY26 results.

Australian Agricultural Company (ASX:AAC) defied North Queensland floods to deliver a 23% jump in operating profit, driven by strong beef pricing and herd valuation gains.

Me Today Limited’s China partner has increased its ownership in the Me Today China trademark to 40% after hitting key revenue targets, reflecting growing traction in the Chinese sports nutrition market.

Acrux has locked in a milestone-based licensing agreement worth up to AUD 5.4 million for Lenzetto®, targeting the Australian menopause therapy market with regulatory and commercial milestones tied to TGA approval and sales performance.

Immuron Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information but pointing to a recent CEO presentation as a possible driver.

UOA Development Bhd’s Q1 2026 results reveal a decline in revenue and profit compared to last year, despite a solid RM130.7 million in new property sales and a substantial unbilled sales pipeline.